1051 related articles for article (PubMed ID: 18068306)
1. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
2. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
[TBL] [Abstract][Full Text] [Related]
3. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
[TBL] [Abstract][Full Text] [Related]
4. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
5. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
6. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
[TBL] [Abstract][Full Text] [Related]
7. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
8. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
Steimer T; Python A; Schulz PE; Aubry JM
Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
[TBL] [Abstract][Full Text] [Related]
10. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
11. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
[TBL] [Abstract][Full Text] [Related]
12. Hormonal differences between psychotic and non-psychotic melancholic depression.
Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
[TBL] [Abstract][Full Text] [Related]
13. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
[TBL] [Abstract][Full Text] [Related]
14. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
[TBL] [Abstract][Full Text] [Related]
16. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F
Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
[TBL] [Abstract][Full Text] [Related]
19. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
Reppermund S; Zihl J; Lucae S; Horstmann S; Kloiber S; Holsboer F; Ising M
Biol Psychiatry; 2007 Sep; 62(5):400-6. PubMed ID: 17188252
[TBL] [Abstract][Full Text] [Related]
20. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
